TransEnterix (TRXC) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
TransEnterix, Inc. Reports Operating Results for the Third Quarter 2016
November 9, 2016 4:05 PM ESTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of 2016.
Recent Highlights
On July 29, 2016, the Company closed its first sale of the Senhance Surgical Robotic System (formerly known as the ALF-X System) to Humanitas Hospital, a research and teaching hospital partnered with Humanitas University Medical School, located in Milan, Italy. On October 4, 2016, the... MoreTransEnterix Announces Senhance Robotic System Program at Imperial College London and Imperial College Healthcare NHS Trust
November 9, 2016 4:01 PM ESTFirst installation of Senhance with a leading medical institution in the United Kingdom
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has installed a Senhance Robotic Surgical System in partnership with Imperial College London and St. Marys Hospital of the Imperial College Healthcare NHS Trust.
Imperial College London and the Imperial College Healthcare NHS Trust are among the leading centers for minimally invasive... More
TransEnterix Announces Distribution Agreement for Australia and New Zealand for Senhance Surgical Robotic System
November 8, 2016 4:30 PM ESTPartners with Getz Healthcare to Lead Robotic Sales, Service and Support
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has expanded distribution of the Senhance Surgical Robotic System (the Senhance). TransEnterix has partnered with Getz Healthcare to be the exclusive distribution partner for the Senhance in the Australian and New Zealand markets.
Australia and New Zealand are key markets in the healthcare industry, with leading... More
